Continuous Crystallization of Cyclosporine: Effect of Operating Conditions on Yield and Purity
暂无分享,去创建一个
Allan S. Myerson | Bernhardt L. Trout | B. Trout | A. Myerson | Jicong Li | Tsai-Ta C. Lai | Jicong Li
[1] P. Vekilov,et al. Distribution coefficients of protein impurities in ferritin and lysozyme crystals Self-purification in microgravity , 2000 .
[2] Zoltan K. Nagy,et al. Fines removal in a continuous plug flow crystallizer by optimal spatial temperature profiles with controlled dissolution , 2013 .
[3] Narayan Variankaval,et al. From Form to Function: Crystallization of Active Pharmaceutical Ingredients , 2008 .
[4] Allan S. Myerson,et al. Continuous Plug Flow Crystallization of Pharmaceutical Compounds , 2010 .
[5] Richard D. Braatz,et al. Advanced control of crystallization processes , 2002, Annu. Rev. Control..
[6] K. Sangwal,et al. On the supersaturation and impurity concentration dependence of segregation coefficient in crystals grown from solutions , 2000 .
[7] P. Poechlauer,et al. Continuous Processing in the Manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms: An Industry Perspective , 2012 .
[8] Allan S. Myerson,et al. Crystallization of Cyclosporine in a Multistage Continuous MSMPR Crystallizer , 2011 .
[9] Ronald W. Rousseau,et al. Distribution of Isomorphic Amino Acids between a Crystal Phase and an Aqueous Solution , 2002 .
[10] Allan S. Myerson,et al. Continuous Crystallization of Aliskiren Hemifumarate , 2012 .
[11] Allan S. Myerson,et al. Development of Continuous Anti-Solvent/Cooling Crystallization Process using Cascaded Mixed Suspension, Mixed Product Removal Crystallizers , 2012 .
[12] Allan S. Myerson,et al. Control of Polymorphism in Continuous Crystallization via Mixed Suspension Mixed Product Removal Systems Cascade Design , 2015 .
[13] James M. B. Evans,et al. End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. , 2013, Angewandte Chemie.
[14] Zoltan K. Nagy,et al. Recent advances in the monitoring, modelling and control of crystallization systems , 2013 .
[15] Dimitrios I. Gerogiorgis,et al. Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study , 2011 .
[16] S. Y. Wong,et al. Development of Continuous Crystallization Processes Using a Single-Stage Mixed-Suspension, Mixed-Product Removal Crystallizer with Recycle , 2012 .
[17] Ronald W. Rousseau,et al. Effect of relative solubility on amino acid crystal purity , 2001 .
[18] B. Trout,et al. Multistage Continuous Mixed-Suspension, Mixed-Product Removal (MSMPR) Crystallization with Solids Recycle , 2016 .
[19] Christopher L. Burcham,et al. Regions of attainable particle sizes in continuous and batch crystallization processes , 2014 .
[20] Gerry Steele,et al. Continuous Crystallization of Pharmaceuticals Using a Continuous Oscillatory Baffled Crystallizer , 2009 .
[21] Richard D Braatz,et al. Advances and new directions in crystallization control. , 2012, Annual review of chemical and biomolecular engineering.
[22] Richard D. Braatz,et al. Application of Continuous Crystallization in an Integrated Continuous Pharmaceutical Pilot Plant , 2014 .